New diabetes clinical trial: Effectiveness of Weight Loss Methods on Lifespan for Metabolic Syndrome

Published on: May 12, 2024 at 11:00PM
Conditions: Metabolic Syndrome
Interventions: Drug: Semaglutide, Empagliflozin; Procedure: Minigastric bypass; Dietary Supplement: Analimentary detoxication; Behavioral: Ramadan fast's weight loss
Sponsors: University Medical Center, Kazakhstan; Ministry of Science and Higher Education of the Republic of Kazakhstan; Nazarbayev University School of Medicine; Nazarbayev University; Astana Medical University
Recruiting
https://ift.tt/5kzNLYg